Former MasterChef Australia contestant Amina Elshafei has bravely opened up about her crippling health condition.

Myasthenia gravis affects both men and women and occurs across all races and ethnicities. Its incidence and prevalence are higher in women under age 50 and in men ages 65 and older.

SCOTTSDALE, Ariz. — June 16, 2025 — The first patient enrolled in a planned international clinical trial has been treated at HonorHealth Research Institute with a new type of immune therapy for those ...

Richard J. Nowak, MD, MS, Yale School of Medicine, explains what some early myasthenia gravis symptoms are and their impact on research efforts. Read More Delays, Disparities in gMG Diagnosis ...

A treatment for myasthenia gravis, a rare muscle wasting condition ... shortness of breath and weakness in the neck, arms and legs. Symptoms usually start in women under 40 and men over 60, but the ...

Fueled by social media, more boys and men are turning to supplements like amino acids, creatine monohydrate, pre-workout drinks or powders, protein bars and whey protein product in an effort to bulk ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Myasthenia gravis (MG) in children and adolescents to age 18 -- juvenile MG -- includes clinically significant developmental ...

Andy Stephenson says the drug led to improvements in his symptoms, but many cannot to afford use it. Skip to content. ... Myasthenia gravis causes fatigue and muscle weakness, double vision, ...

Concluding a recent interview with Jonathan Strober, MD, an investigator on the phase 2/3 Vibrance-MG study (NCT05265273) exploring pediatric use of nipocalimab for generalized myasthenia gravis ...

This article provides a thorough overview of the pathophysiology and current treatment options for myasthenia gravis, an autoimmune and antibody-mediated neuromuscular disease. News & Perspective ...

ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND ...